52 North Health is focused on enhancing healthcare for cancer patients, specifically those undergoing chemotherapy, by providing a portable and easy-to-use medical device. This device employs artificial intelligence to assess the risk of neutropenic sepsis, a serious and potentially fatal side effect of chemotherapy. Through a finger prick blood test and a corresponding digital platform, the device measures a patient's neutrophil count and C-reactive protein (CRP) levels at home. This functionality allows for timely identification of patients at risk of sepsis, thereby improving their safety and quality of life. By facilitating rapid management of their condition, 52 North Health offers a reliable and cost-effective solution for cancer patients.
Oncoshot is a private company based in Singapore that facilitates access to cancer clinical trials for patients, caregivers, and oncologists. Its platform addresses the complexities of finding suitable clinical trials by enabling patients to share their medical data with trial institutes and sponsors, significantly reducing the time required for trial searches from weeks to mere minutes. By connecting leading cancer hospitals and industry partners, Oncoshot supports a data-driven ecosystem that enhances treatment options and empowers patients to take control of their cancer care journey. The company's operations are regulated by Singapore's Ministry of Health and Health Services Authority, ensuring compliance with local healthcare standards.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.